Investors Seek GLP-1 Alternatives After Nausea Hurdles
A new wave of weight-loss therapies aims to beat current GLP-1 drugs by reducing side effects and daily dosing. Inves...
Stock indices move on earnings, policy changes, and macro data. This intro covers the core catalysts that drive daily swings.
23,761 articlesA new wave of weight-loss therapies aims to beat current GLP-1 drugs by reducing side effects and daily dosing. Inves...
A surge of scams targets buyers who think they found cheap farm equipment on social media. This guide explains how th...
Intel surged about 8% in midday trading, topping gains among the mega-cap chip names. The move comes as investors wei...
Retirees are flocking to Clorox as the market bets on continued high yields. The company offers a compelling 5.5% div...
SpaceX reportedly acquires Cursor, the AI coding tool from Anysphere, for strategic reasons beyond competition. This ...
Retail buzz around Celsius, Chewy, and Estée Lauder is pulsing through markets as earnings shape the near-term outloo...
A brutal European summer is forcing households to grapple with bigger energy bills and rising health costs as heat wa...
A high, steady dividend from Pfizer and peers draws inflows as retirees seek reliable income amid shifts in COVID-era...
As markets swing, a trio of unloved names—general mills, mattel, and mohawk—are drawing renewed attention from retire...
A rising dividend-focused approach suggests a portfolio that pays more can replace a minimum-wage check, but it deman...
SK Hynix rode a Nasdaq debut to a turning point in AI hardware, with a $26.5 billion raise and 58% HBM market share. ...
The rumor that meta platforms launching cloud has investors rethinking cloud strategy. Here’s what it could mean for ...